About Novella Clinical
Novella Clinical is a Healthcare company based in Morrisville (United States) founded in 1998, and was acquired by Quintiles in August 2013. Specialty CRO focussed exclusively solely on the needs of small to mid-sized oncology companies and medical device and diagnostics companies. Novella Clinical has completed 1 acquisition, including Prologue Research International. Its chief executive, as recorded, is Nick Dyer. Novella Clinical offers products and services including Clinical Development Services, Therapeutic Expertise, and Insights and Resources. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is IQVIA Biotech. Its competitors include Aster Insights, CancerVax and Oncotherapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Novella Clinical was founded in 1998 and is based in Morrisville, United States. As an ISO 9001:2008 certified full-service contract research organization, operations are centered on small to mid-sized companies in oncology, medical devices, and diagnostics. Services encompass regulatory planning, project management, clinical monitoring, data management, safety management, medical writing, quality assurance, and post-marketing strategies.
- Headquarters Morrisville, United States
- Stage Acquired
- SectorsHealthcare
- Website novellaclinical.com
- Social LinkedIn X
- Acquired by Quintiles (Aug 2013)
- Legal Name Iqvia Biotech
- Investors
- Investments & Acquisitions
- Acquired byQuintiles
(Aug 2013)
Products & Services of Novella Clinical
Novella Clinical offers a comprehensive portfolio of products and services, including Clinical Development Services, Therapeutic Expertise, and Insights and Resources.
Supports drug development trials in oncology and other therapeutics.
Provides specialized strategies for areas like neurology and dermatology.
Offers reports and resources for biotech innovation and patient impact.
Investors in Novella Clinical
Novella Clinical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IQVIA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare advancements are driven by IQVIA through connected intelligence. | quintiles.com | United States |
Investor details for Novella Clinical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novella Clinical
1270 people are tracked at Novella Clinical (702 in leadership, 9 in board & advisors, 559 in team).
| Name | Role | Group |
|---|---|---|
Nick Dyer | CEO | Leadership |
Peter Scilipote | Vice President, Business Transformation | Leadership |
Lynda Curtin | Director Clinical Operations -site Management | Leadership |
Oana Borse | Director, Strategic Sourcing R&ds | Leadership |
David Peig | Senior Director - Rare Disease BU & GTM Strategy | Leadership |
Mike Davis | Sr. Director, Strategic Business Development (r&d Solutions) | Leadership |
Ryan Deterding | Vice President And Global Account Director | Leadership |
Iqbal Thaker | Assoc. Director - IT Projects | Leadership |
Jennifer Millard | Vice President | Leadership |
Arthur Jenkins | Senior Director, Porfolio Project Management And Development Engineering | Leadership |
Manoj Singh | Director Of Software Engineering | Leadership |
Ester Pavon | Associate Director, Clinical Project Management | Leadership |
Nuno Dias | Senior Director, IT (head Of Technology) | Leadership |
Alexey Levashov | Associate Clinical Project Management Director | Leadership |
Chris Nickum | Vice President And General Manager, Commercial Solutions And Insights Hub (csih) | Leadership |
Fumihiko Ugajin | President - Japan | Leadership |
Stormie R. Crouch | Senior Director, Business Development | Leadership |
Avery Pasch | Account Director | Leadership |
Abbygail Boswell | International Project Associate Director | Leadership |
Susan Grant Schneider | Senior Vice President | Leadership |
1250 more people are available in the full profile.
Complete people profiles for Novella Clinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novella Clinical
Novella Clinical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Prologue Research International.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Oncology focussed CRO, acquired by Novella Clinical in 2010 | procro.com | Columbus, United States | 1998 | Jun 2010 | β’β’β’β’ |
Complete acquisition details for Novella Clinical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Novella Clinical
3 dated milestones of Novella Clinical across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Novella Clinical is founded.
- Acquisition Acquires Prologue Research International.
- Exit Acquired by Quintiles.
Competitors of Novella Clinical
Novella Clinical has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, CancerVax and Oncotherapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asterinsights.com | 2006 | Tampa, United States | $75M | 115 | Contract-based oncology clinical trial services are provided by Aster Insights. | |
| cancervax.com | 1998 | Carlsbad, United States | $55M | Cancer vaccine research and development is conducted by CancerVax. | ||
| oncotherapeutics.com | 1988 | West Hollywood, United States | $8.3M | Preclinical and clinical oncology drug development services are provided. |
Detailed competitors of Novella Clinical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Novella Clinical
Websites that share an audience with Novella Clinical (novellaclinical.com).
Websites whose visitors overlap most with Novella Clinical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rhoworld.com | 100% | 7.9K | #2,859,814 | View details | |
| clinipace.com | 92% | View details | |||
| quanticate.com | 83% | #1,287,633 | View details | ||
theconferenceforum.org | theconferenceforum.org | 79% | #1,939,042 | β | |
| iconplc.com | 78% | 476.9K | #92,950 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 17 similar websites and full traffic analytics for Novella Clinical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Novella Clinical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novella Clinical
Novella Clinical was founded in 1998.
Novella Clinical is headquartered in Morrisville, United States.
Nick Dyer is the CEO of Novella Clinical, as recorded in our data.
Novella Clinical was founded in 1998 and is based in Morrisville, United States. As an ISO 9001:2008 certified full-service contract research organization, operations are centered on small to mid-sized companies in oncology, medical devices, and diagnostics. Services encompass regulatory planning, project management, clinical monitoring, data management, safety management, medical writing, quality assurance, and post-marketing strategies.
Novella Clinical's top competitors include CancerVax, Aster Insights and Oncotherapeutics.
Novella Clinical offers Clinical Development Services, Therapeutic Expertise, and Insights and Resources.
Novella Clinical has made 1 acquisition, including Prologue Research International.
Novella Clinical has 1 investor. Key investors include IQVIA.
Novella Clinical operates through Iqvia Biotech.
Yes. Novella Clinical was acquired by Quintiles in August 2013.
